Literature DB >> 21161231

[TTF-1 (8G7G3/1) positive colon adenocarcinoma: diagnostic implications].

H G Reis1, C H D Metz, H A Baba, N Bornfeld, K W Schmid, K A Metz.   

Abstract

Immunohistochemical evaluation of primary and secondary (adeno-) carcinomas of the lung often includes utilisation of two different clones (8G7G3/1 or SPT24) of TTF-1 (thyroid transcription factor 1) antibodies. In a subgroup of adenocarcinomas with a primary site other than the lung a positive reaction of clone SPT24 and also of clone 8G7G3/1 is described. We report on a patient with TTF-1 (clone 8G7G3/1) positive adenocarcinoma of the colon with metastases to the eye and lung and discuss TTF-1 based diagnostic considerations.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21161231     DOI： 10.1007/s00292-010-1414-y

Source DB:  PubMed          Journal:  Pathologe        ISSN： 0172-8113            Impact factor:   1.011


  6 in total

1.  Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.

Authors:  O Kaufmann; M Dietel
Journal:  Histopathology       Date:  2000-01       Impact factor: 5.087

2.  Positive immunostaining for thyroid transcription factor-1 in colorectal adenocarcinoma using the 8G7G3/1 monoclonal antibody.

Authors:  N A C S Wong; H Kamel; E A Sheffield; M Sohail
Journal:  J Clin Pathol       Date:  2008-09       Impact factor: 3.411

3.  Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution.

Authors:  D Penman; I Downie; F Roberts
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.

Authors:  Yue-Chiu Su; Yu-Chang Hsu; Chee-Yin Chai
Journal:  Kaohsiung J Med Sci       Date:  2006-01       Impact factor: 2.744

5.  Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.

Authors:  Andres Matoso; Kamaljeet Singh; Rafik Jacob; Wesley O Greaves; Rosemarie Tavares; Lelia Noble; Murray B Resnick; Ronald A Delellis; Li J Wang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-03

6.  Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.

Authors:  Shu-Chuan Tsao; Yue-Chiu Su; Sheng-Lan Wang; Chee-Yin Chai
Journal:  Kaohsiung J Med Sci       Date:  2007-07       Impact factor: 2.744
  6 in total
  6 in total

Review 1.  Immunohistochemistry in Diagnostic Parathyroid Pathology.

Authors:  Lori A Erickson; Ozgur Mete
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

2.  [Two synchronous malignancies in a single nephrectomy specimen].

Authors:  J Hrudka; V Eis; J Šach; P Klézl; S Schilling; D Bandke
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

Review 3.  [The role of pathology in the diagnostics of CUP syndrome].

Authors:  A Stenzinger; M Kriegsmann; W Weichert
Journal:  Radiologe       Date:  2014-02       Impact factor: 0.635

4.  TTF-1 Expression in Rectal Adenocarcinoma: A Case Report and Review of the Literature.

Authors:  Astrid Belalcazar; Uma Krishnamurti; Walid Shaib
Journal:  Case Rep Oncol       Date:  2016-11-18

Review 5.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

6.  Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma.

Authors:  Tingting Bian; Jinli Zhao; Jia Feng; Qing Zhang; Li Qian; Jian Liu; Daishan Jiang; Yifei Liu; Jianguo Zhang
Journal:  Oncotarget       Date:  2017-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.